Welcome to kongre.net

NC

SummitIn person

Novel CNS Biomarkers Summit Europe

Hosted by Hanson Wade

30 November – 2 December 2026
Add to calendar
Apple / Outlook (.ics)Google Calendar
Welcome to kongre.net
Events Categories News Jobs
Hilton London Olympia, London, United Kingdom
Clinical MedicineNeurologyBasic MedicinePharmacology & Toxicology

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net

Welcome to kongre.net

Official website

Programme

Published

21 sessions across 3 days

16 speakers

Browse programme

Registration

Registration is handled by the organiser

Go to registration See registration fees

Key facts

Novel CNS Biomarkers Summit Europe is a summit held 30 November – 2 December 2026 in Hilton London Olympia, London, United Kingdom, organised by Hanson Wade.

Dates:: 30 November – 2 December 2026
Format:: In person
Venue:: Hilton London Olympia, London, United Kingdom
Subjects:: Neurology, Pharmacology & Toxicology
Organiser:: Hanson Wade
Official website:: cns-biomarkers-europe.com

The Novel CNS Biomarkers Summit Europe is a premier gathering dedicated exclusively to the advancement of fluid, imaging, and digital biomarkers for CNS drug development. Organised by Hanson Wade, the event takes place from 30th November to 2nd December 2026 at the Hilton London Olympia in London, United Kingdom. It brings together over 60 biomarker, translational medicine, neuroscience, and clinical development leaders from across Europe to address the high rate of clinical trial failures and accelerate precision-driven drug development for indications such as Alzheimer's disease, Parkinson's disease, ALS, and schizophrenia.

Conference theme

Innovating Multimodal Biomarkers for Rare & Common CNS Indications

Programme highlights

View full programme

Mon, 30 Nov 2026Mastering α-Synuclein Biomarkers Across Fluid & Imaging Modalities to Accelerate Parkinson’s Disease Drug DevelopmentWorkshop2 sessions this day
Tue, 1 Dec 2026Chair’s Opening RemarksPlenary9 sessions this day
Wed, 2 Dec 2026Chair’s Opening RemarksPlenary10 sessions this day

Speakers

View all 16 speakers

Jens Mikkelsen
University of Copenhagen
Elevating Synaptic Biomarkers in Epilepsy: Unlocking the Potential of CSF & Plasma SV2A for Structural Disease Diagnosis
Aleksandra Zemla
Dompé
Roundtable Discussion: Advancing Ultrasensitive Assays from Research-Grade to Clinical-Grade – Analytical Validation, Quality Control & Standardisation Strategies
Valerie Daggett
AltPep
Exploring How Toxic Oligomer Biomarkers Can Improve Early Detection & Monitoring in Alzheimer’s & Parkinson’s Disease
Nanh Nguyen
UCB
Overcoming Assay Harmonisation & Validation Challenges to Ensure Cross-Trial Comparability & Regulatory Acceptance
Wolfgang Liedtke
Duke University
Fusing Imaging & Digital Biomarkers: Building Regulator-Ready Multimodal Endpoints for Alzheimer’s, ALS & Rare CNS Trials
Lluís Riera Ponsati
Neumirna Therapeutics
Fireside Chat: New Efforts & Technologies to Avoid Invasive Lumbar Puncture – Comparing Blood-Based Biomarkers, Imaging Biomarkers, Olfactory Neurons, Extracellular Vesicles & Emerging Minimally Invasive Approaches
Kiri Granger
Monument Therapeutics
Moving Beyond Symptom-Based Psychiatry: Using Digital Cognitive Biomarkers to Stratify Patients, Confirm Pharmacology & Advance Precision Medicine in Schizophrenia
Elia Hall
Roche
Managing Multi-Site Biomarker Collection, Processing & Logistics – Ensuring Sample Integrity, Data Quality & Operational Success Across Global Trials

Venue & travel Hilton London OlympiaLondon, United KingdomVenue details About the organiser Hanson Wade4 more events from this organiserOrganiser profile Who is going? See who is planning to attend and say you are goingSee who is going

Organiser and contact

Host organisation

Hanson Wade 4 more events from Hanson Wade

Contact

Event secretary:: Isobel Slater
Email:: [email protected]

Advertisement

Related events